Journal of labelled compounds and radiopharmaceuticals p. 665 - 673 (2002)
Update date:2022-08-17
Topics:
Schneider
Price
Chapman
The title compound, 3a, when exchange labeled with 125I results in three new labeled products. The major labeled product (84.1%) is 1-(4-deoxy-4-iodo-β-L-arabinopyranosyl)-2-nitroimidazole, 3b, that could result from inversion of configuration at C-4. Exchange labeling carried out under conditions of kinetic control yielded dramatically different product ratios than thermodynamic equilibrium reactions. Confirmation of these results was established by extensive 1H NMR spectral analyses. A possible mechanism is presented. Copyright
View MoreContact:USA:563-513-3839
Address:No.121TANGU EAST STREET,SHIJIAZHAUNG,CHINA
Taixing Joxin Bio-tec Co.,Ltd.
website:http://www.joxbio.com
Contact:86-523-87558858 87612088
Address:No.88, chengdong industrial park
SHIFANG SUHONG CHEMICAL CO.,LTD
Contact:+86-838-2224563
Address:Room 1207 Zongchen Sunshine No.128 Taishan South Road,Deyang City,Sichuan China
Jiangsu Jiuri Chemical Co.,Ltd.
Contact:+86-519-82118868
Address:Tianwang Town, Jurong City, Jiangsu Province, China
Nanjing Samwon International Limited
Contact:+86-25-84873444
Address:1108, BLDG B, New Century Plaza, No 1, South Taiping Rd.,
Doi:10.1016/j.molliq.2020.113224
(2020)Doi:10.1021/jm301422h
(2013)Doi:10.1016/j.apcata.2015.11.014
(2016)Doi:10.1002/hlca.200490175
(2004)Doi:10.1055/s-2001-14655
(2001)Doi:10.1039/c9gc01043b
(2019)